Skip to main content
SpringerLink
Log in

Sirtuin 6, a possible therapeutic target for type 2 diabetes

  • Review
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Sirtuin 6 (SIRT6), one of the seven members of mammalian sirtuin family, localizes in the nucleus and primarily regulates chromatin signaling and genomic integrity. Recent studies established the critical role of SIRT6 in the pathophysiology of metabolic disease, as well as its roles in longevity and cancer. These roles that were determined by genetic studies include promoting pancreatic insulin secretion, inhibiting hepatic gluconeogenesis and triglyceride synthesis, and suppressing adiposity, suggesting that SIRT6 activators are promising molecules for treating obesity and diabetes. In contrast, a recent study showed that a synthetic inhibitor of SIRT6 improved glucose tolerance in a type 2 diabetes mouse model, associated with increased glycolysis and the expression of glucose transporter GLUT-1 and 4 in skeletal muscle, providing proof-of-concept evidence of SIRT6 inhibition as a treatment for diabetes. This review summarizes the confounding findings on the role of SIRT6 in metabolic homeostasis and discusses the possible relationships of these findings as they relate to the use of SIRT6 as a therapeutic target for type 2 diabetes and related diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Anderson JG, Ramadori G, Ioris RM, Galie M, Berglund ED, Coate KC, Fujikawa T, Pucciarelli S, Moreschini B, Amici A, Andreani C, Coppari R (2015) Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6. Mol Metab 4:846–856

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anstee QM, Targher G, Day CP (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330–344

    Article  CAS  PubMed  Google Scholar 

  • Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW, Park SW, Kim SW (2011) Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4 year retrospective longitudinal study. Diabetes Care 34:727–729

    Article  PubMed  PubMed Central  Google Scholar 

  • Benner C, Van Der Meulen T, Caceres E, Tigyi K, Donaldson CJ, Huising MO (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620

    Article  PubMed  PubMed Central  Google Scholar 

  • Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvari M, Piper MD, Hoddinott M, Sutphin GL, Leko V, Mcelwee JJ, Vazquez-Manrique RP, Orfila AM, Ackerman D, Au C, Vinti G, Riesen M, Howard K, Neri C, Bedalov A, Kaeberlein M, Soti C, Partridge L, Gems D (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477:482–485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Canto C, Auwerx J (2009) Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab 20:325–331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen Q, Hao W, Xiao C, Wang R, Xu X, Lu H, Chen W, Deng CX (2017) SIRT6 is essential for adipocyte differentiation by regulating mitotic clonal expansion. Cell Rep 18:3155–3166

    Article  CAS  PubMed  Google Scholar 

  • Coppari R, Bjorbaek C (2012) Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 11:692–708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui X, Yao L, Yang X, Gao Y, Fang F, Zhang J, Wang Q, Chang Y (2017) SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK. Am J Physiol Endocrinol Metab 313:E493–E505

    Article  PubMed  Google Scholar 

  • De Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, Cobelli C, Fadini GP, Avogaro A (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59:1006–1015

    Article  PubMed  PubMed Central  Google Scholar 

  • Dominy JE Jr, Lee Y, Jedrychowski MP, Chim H, Jurczak MJ, Camporez JP, Ruan HB, Feldman J, Pierce K, Mostoslavsky R, Denu JM, Clish CB, Yang X, Shulman GI, Gygi SP, Puigserver P (2012) The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol Cell 48:900–913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Etchegaray JP, Zhong L, Mostoslavsky R (2013) The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease. Curr Top Med Chem 13:2991–3000

    Article  CAS  PubMed  Google Scholar 

  • Feldman JL, Baeza J, Denu JM (2013) Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J Biol Chem 288:31350–31356

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gottlieb S, Esposito RE (1989) A new role for a yeast transcriptional silencer gene, SIR2, in regulation of recombination in ribosomal DNA. Cell 56:771–776

    Article  CAS  PubMed  Google Scholar 

  • He B, Hu J, Zhang X, Lin H (2014) Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors. Org Biomol Chem 12:7498–7502

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiang H, Khan S, Wang Y, Charron G, He B, Sebastian C, Du J, Kim R, Ge E, Mostoslavsky R, Hang HC, Hao Q, Lin H (2013) SIRT6 regulates TNF-alpha secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496:110–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ka SO, Bang IH, Bae EJ, Park BH (2017) Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor. FASEB J 31:3999–4010

    Article  PubMed  Google Scholar 

  • Kaeberlein M, Mcvey M, Guarente L (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13:2570–2580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kanfi Y, Shalman R, Peshti V, Pilosof SN, Gozlan YM, Pearson KJ, Lerrer B, Moazed D, Marine JC, De Cabo R, Cohen HY (2008) Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett 582:543–548

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kanfi Y, Peshti V, Gil R, Naiman S, Nahum L, Levin E, Kronfeld-Schor N, Cohen HY (2010) SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 9:162–173

    Article  CAS  PubMed  Google Scholar 

  • Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, Bar-Joseph Z, Cohen HY (2012) The sirtuin SIRT6 regulates lifespan in male mice. Nature 483:218–221

    Article  CAS  PubMed  Google Scholar 

  • Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, Mccord RA, Ongaigui KC, Boxer LD, Chang HY, Chua KF (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136:62–74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kemnitz JW, Roecker EB, Weindruch R, Elson DF, Baum ST, Bergman RN (1994) Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am J Physiol 266:E540–E547

    CAS  PubMed  Google Scholar 

  • Kim HS, Xiao C, Wang RH, Lahusen T, Xu X, Vassilopoulos A, Vazquez-Ortiz G, Jeong WI, Park O, Ki SH, Gao B, Deng CX (2010) Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab 12:224–236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Klar AJ, Strathern JN, Broach JR, Hicks JB (1981) Regulation of transcription in expressed and unexpressed mating type cassettes of yeast. Nature 289:239–244

    Article  CAS  PubMed  Google Scholar 

  • Koltai E, Szabo Z, Atalay M, Boldogh I, Naito H, Goto S, Nyakas C, Radak Z (2010) Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech Ageing Dev 131:21–28

    Article  CAS  PubMed  Google Scholar 

  • Kuang J, Zhang Y, Liu Q, Shen J, Pu S, Cheng S, Chen L, Li H, Wu T, Li R, Li Y, Zou M, Zhang Z, Jiang W, Xu G, Qu A, Xie W, He J (2017) Fat-specific Sirt6 ablation sensitizes mice to high-fat diet-induced obesity and insulin resistance by inhibiting lipolysis. Diabetes 66:1159–1171

    Article  CAS  PubMed  Google Scholar 

  • Kugel S, Mostoslavsky R (2014) Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem Sci 39:72–81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lane MA, Ingram DK, Roth GS (1999) Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. Toxicol Sci 52:41–48

    Article  CAS  PubMed  Google Scholar 

  • Lee Y, Ka SO, Cha HN, Chae YN, Kim MK, Park SY, Bae EJ, Park BH (2017) Myeloid Sirtuin 6 deficiency causes insulin resistance in high-fat diet-fed mice by eliciting macrophage polarization toward an M1 phenotype. Diabetes 66:2659–2668

    Article  PubMed  Google Scholar 

  • Liszt G, Ford E, Kurtev M, Guarente L (2005) Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 280:21313–21320

    Article  CAS  PubMed  Google Scholar 

  • Luu L, Dai FF, Prentice KJ, Huang X, Hardy AB, Hansen JB, Liu Y, Joseph JW, Wheeler MB (2013) The loss of Sirt1 in mouse pancreatic beta cells impairs insulin secretion by disrupting glucose sensing. Diabetologia 56:2010–2020

    Article  CAS  PubMed  Google Scholar 

  • Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16:4623–4635

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Michishita E, Mccord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, Chua KF (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452:492–496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Michishita E, Mccord RA, Boxer LD, Barber MF, Hong T, Gozani O, Chua KF (2009) Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8:2664–2666

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moschen AR, Wieser V, Gerner RR, Bichler A, Enrich B, Moser P, Ebenbichler CF, Kaser S, Tilg H (2013) Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. J Hepatol 59:1315–1322

    Article  CAS  PubMed  Google Scholar 

  • Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, Cheng HL, Kennedy C, Nunez N, Bronson R, Frendewey D, Auerbach W, Valenzuela D, Karow M, Hottiger MO, Hursting S, Barrett JC, Guarente L, Mulligan R, Demple B, Yancopoulos GD, Alt FW (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124:315–329

    Article  CAS  PubMed  Google Scholar 

  • Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Meneur C, Permutt MA, Imai S (2005) Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2:105–117

    Article  CAS  PubMed  Google Scholar 

  • Nemoto S, Fergusson MM, Finkel T (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306:2105–2108

    Article  CAS  PubMed  Google Scholar 

  • Pan H, Guan D, Liu X, Li J, Wang L, Wu J, Zhou J, Zhang W, Ren R, Zhang W, Li Y, Yang J, Hao Y, Yuan T, Yuan G, Wang H, Ju Z, Mao Z, Li J, Qu J, Tang F, Liu GH (2016) SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res 26:190–205

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parenti MD, Grozio A, Bauer I, Galeno L, Damonte P, Millo E, Sociali G, Franceschi C, Ballestrero A, Bruzzone S, Del Rio A, Nencioni A (2014) Discovery of novel and selective SIRT6 inhibitors. J Med Chem 57:4796–4804

    Article  CAS  PubMed  Google Scholar 

  • Rahnasto-Rilla M, Kokkola T, Jarho E, Lahtela-Kakkonen M, Moaddel R (2016) N-acylethanolamines bind to SIRT6. ChemBioChem 17:77–81

    Article  CAS  PubMed  Google Scholar 

  • Rahnasto-Rilla MK, Mcloughlin P, Kulikowicz T, Doyle M, Bohr VA, Lahtela-Kakkonen M, Ferrucci L, Hayes M, Moaddel R (2017) The identification of a SIRT6 activator from brown algae Fucus distichus. Mar Drugs 15:190

    Article  PubMed Central  Google Scholar 

  • Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, Yamada KA, Imai S (2013) Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 18:416–430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schwer B, Schumacher B, Lombard DB, Xiao C, Kurtev MV, Gao J, Schneider JI, Chai H, Bronson RT, Tsai LH, Deng CX, Alt FW (2010) Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sci USA 107:21790–21794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma A, Diecke S, Zhang WY, Lan F, He C, Mordwinkin NM, Chua KF, Wu JC (2013) The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J Biol Chem 288:18439–18447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sociali G, Galeno L, Parenti MD, Grozio A, Bauer I, Passalacqua M, Boero S, Donadini A, Millo E, Bellotti M, Sturla L, Damonte P, Puddu A, Ferroni C, Varchi G, Franceschi C, Ballestrero A, Poggi A, Bruzzone S, Nencioni A, Del Rio A (2015) Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics. Eur J Med Chem 102:530–539

    Article  CAS  PubMed  Google Scholar 

  • Sociali G, Magnone M, Ravera S, Damonte P, Vigliarolo T, Von Holtey M, Vellone VG, Millo E, Caffa I, Cea M, Parenti MD, Del Rio A, Murone M, Mostoslavsky R, Grozio A, Nencioni A, Bruzzone S (2017) Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model. FASEB J 31:3138–3149

    Article  CAS  PubMed  Google Scholar 

  • Song MY, Wang J, Ka SO, Bae EJ, Park BH (2016) Insulin secretion impairment in Sirt6 knockout pancreatic beta cells is mediated by suppression of the FoxO1-Pdx1-Glut2 pathway. Sci Rep 6:30321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26:832–836

    Article  PubMed  Google Scholar 

  • Tao R, Xiong X, Depinho RA, Deng CX, Dong XC (2013a) FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expression. J Biol Chem 288:29252–29259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tao R, Xiong X, Depinho RA, Deng CX, Dong XC (2013b) Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. J Lipid Res 54:2745–2753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tasselli L, Xi Y, Zheng W, Tennen RI, Odrowaz Z, Simeoni F, Li W, Chua KF (2016) SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence. Nat Struct Mol Biol 23:434–440

    Article  CAS  PubMed  Google Scholar 

  • Tasselli L, Zheng W, Chua KF (2017) SIRT6: novel mechanisms and links to aging and disease. Trends Endocrinol Metab 28:168–185

    Article  CAS  PubMed  Google Scholar 

  • Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3):S16–S21

    Article  CAS  PubMed  Google Scholar 

  • Xiao C, Kim HS, Lahusen T, Wang RH, Xu X, Gavrilova O, Jou W, Gius D, Deng CX (2010) SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem 285:36776–36784

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xiong X, Wang G, Tao R, Wu P, Kono T, Li K, Ding WX, Tong X, Tersey SA, Harris RA, Mirmira RG, Evans-Molina C, Dong XC (2016) Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells. Diabetologia 59:151–160

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xiong X, Zhang C, Zhang Y, Fan R, Qian X, Dong XC (2017) Fabp4-Cre-mediated Sirt6 deletion impairs adipose tissue function and metabolic homeostasis in mice. J Endocrinol 233:307–314

    Article  PubMed  Google Scholar 

  • Yang B, Zwaans BM, Eckersdorff M, Lombard DB (2009) The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 8:2662–2663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang SJ, Choi JM, Chang E, Park SW, Park CY (2014) Sirt1 and Sirt6 mediate beneficial effects of rosiglitazone on hepatic lipid accumulation. PLoS ONE 9:e105456

    Article  PubMed  PubMed Central  Google Scholar 

  • Ye X, Li M, Hou T, Gao T, Zhu WG, Yang Y (2017) Sirtuins in glucose and lipid metabolism. Oncotarget 8:1845–1859

    PubMed  Google Scholar 

  • You W, Rotili D, Li TM, Kambach C, Meleshin M, Schutkowski M, Chua KF, Mai A, Steegborn C (2017) Structural basis of Sirtuin 6 activation by synthetic small molecules. Angew Chem Int Ed Engl 56:1007–1011

    Article  CAS  PubMed  Google Scholar 

  • Zhang P, Tu B, Wang H, Cao Z, Tang M, Zhang C, Gu B, Li Z, Wang L, Yang Y, Zhao Y, Wang H, Luo J, Deng CX, Gao B, Roeder RG, Zhu WG (2014) Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc Natl Acad Sci USA 111:10684–10689

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang X, Khan S, Jiang H, Antonyak MA, Chen X, Spiegelman NA, Shrimp JH, Cerione RA, Lin H (2016) Identifying the functional contribution of the defatty-acylase activity of SIRT6. Nat Chem Biol 12:614–620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhong L, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, Mostoslavsky R (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140:280–293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, Woosuk University, 443 Samnye-ro, Wanju, Jeonbuk, 55338, Republic of Korea

    Eun Ju Bae

Authors
  1. Eun Ju Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eun Ju Bae.

Ethics declarations

Conflict of interest

The author confirm that this article has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bae, E.J. Sirtuin 6, a possible therapeutic target for type 2 diabetes. Arch. Pharm. Res. 40, 1380–1389 (2017). https://doi.org/10.1007/s12272-017-0989-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-017-0989-8

Keywords

Search

Navigation